Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

183.69 +34.90 (+23.46%)
Streaming Delayed Price Updated: 2:43 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
38 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $... 
Via Benzinga
News headline image
Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA. 
Via InvestorPlace
News headline image
Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent ↗
The company agreed to the FDA's post-marketing requirements for a depression drug. 
Via Investor's Business Daily
News headline image
Axsome Therapeutics Stock Is Surging: Here's Why ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed... 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More ↗
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates ↗
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with... 
Via Benzinga
News headline image
Peering Into Axsome Therapeutics Inc's Recent Short Interest ↗
Axsome Therapeutics Inc's (NASDAQ:AXSM) short percent of float has risen 15.16% since its last report. The company recently reported that it has 4.42 million shares sold short,... 
Via Benzinga
News headline image
Why Axsome Therapeutics Stock Is Trading Higher ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ). 
Via Benzinga
News headline image
Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) has  
Via Benzinga
News headline image
Best Biotech Stocks To Buy In 2022 ↗
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
News headline image
Axsome Therapeutics: Q4 Earnings Insights ↗
Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
Via Benzinga
News headline image
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics ↗
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers ContraFect (NASDAQ:CFRX) stock mo... 
Via Benzinga
News headline image
2 Top Biotech Stocks Ready for a Bull Run ↗
Both of these companies have potential catalysts on the way. 
Via The Motley Fool
News headline image
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript ↗
AXSM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Why Axsome Therapeutics Stock Is Rising Today ↗
The company provided its third-quarter update. 
Via The Motley Fool
News headline image
2 Biotech Stocks Poised for Jaw-Dropping Growth ↗
These two tiny drugmakers could make early shareholders wealthy. 
Via The Motley Fool
Topics Stocks
News headline image
Why Axsome Therapeutics Stock Rocketed Higher This Week ↗
Optimism among investors is growing for the possible approval of the biotech's MDD drug. 
Via The Motley Fool
News headline image
1 Beaten-Down Stock With 10X Potential ↗
This biotech is down, but it isn't out just yet. 
Via The Motley Fool
News headline image
45 Biggest Movers From Yesterday ↗
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
News headline image
Why Axsome Therapeutics Stock Caught Fire in September ↗
This beaten-down biotech regained some lost ground last month. 
Via The Motley Fool
News headline image
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 09/29/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Axsome Therapeutics, Inc. 
Via SBWire
News headline image
Why Wall Street Thinks This Biotech Stock Can Triple Your Money ↗
The risks are huge, but so are the potential returns. 
Via The Motley Fool
News headline image
Why Axsome Therapeutics Stock Cratered in August ↗
An unexpected regulatory setback weighed heavily on the biotech's shares last month. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.